Lophius Biosciences
Lophius Biosciences is a biotech company focusing on research, development and marketing in the field of infectious and autoimmune diseases.
We aim to make personalized therapies possible by using innovative diagnostic products to measure pathogen-specific immune responses. The core competences of Lophius Biosciences are in the areas of infectious diseases as well as transplantation and T-cell immunology.
25.04.2012
Lophius Biosciences performs successful clinical validation for T-TrackĀ® CMV/EBV test systems
read more24.10.2011
Lophius Biosciences presents T-Track© CMV/EBV tests at congress after conclusion of product development and initiation of a clinical validation study
read more18.07.2011
Lophius Biosciences closes additional financing round with current investors totaling 1.4 million EUR
read more more news

